Short Title:
Biomarkers in Human RT
Responsible HRP Element:
Space Radiation
Funding Status:
Active - Currently funded and in progress
|
Procurement Mechanism(s):
|
|
Aims:
Aim 1: Assess for cardiac toxicity in patients treated with RT to the chest.
Aim 2: Assess for an association between 3D imaging findings suggestive of cardiac injury and radiation dosimetry.
Aim 3: Explore the association of radiation exposure with serum biomarker levels.
Other Resources
| Other Resources Needed?
|
Yes
|
Category:
Risk Characterization, Quantification
Subcategory:
Evidence or Risk Characterization
Description:
The deliverable will be an evaluation of MRI as noninvasive imaging modality for detection of early indicators of cardiotoxicity following radiotherapy, compared with electrocardiograms.
Internal Customers:
None
External Customers:
None
Category:
Risk Characterization, Quantification
Subcategory:
Evidence or Risk Characterization
Description:
The deliverable will be an evaluation of serum markers and other cardiovascular parameters for detection of early indicators of cardiotoxicity following radiotherapy.
Internal Customers:
None
External Customers:
None